| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $33.5M | — | -8.0% |
| SG&A Expense | $15.2M | — | +32.7% |
| Operating Income | -$48.8M | — | -14.7% |
| Pre-tax Income | -$45.5M | — | -14.2% |
| Income Tax | $1K | — | -97.1% |
| Net Income | -$45.5M | — | -14.1% |
| EPS (Basic) | -$0.32 | — | +11.1% |
| EPS (Diluted) | -$0.32 | — | +11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $157.8M | +40.6% | +170.1% |
| Short-term Investments | $222.0M | -3.8% | +40.3% |
| Current Assets | $392.3M | +10.9% | +74.4% |
| Total Assets | $435.8M | +9.3% | +58.9% |
| Current Liabilities | $14.3M | -33.9% | -60.1% |
| Total Liabilities | $44.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.4M | — | -6.4% |
| Capital Expenditures | -$2K | — | -103.9% |
| Investing Cash Flow | $9.6M | — | -68.5% |
| Financing Cash Flow | $79.8M | — | — |
| Free Cash Flow | -$44.4M | — | -6.3% |
| -58.8% |
| Stockholders' Equity | $391.5M | +13.1% | +134.8% |